Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,851 | -37,543 | -62,025 | -57,776 | -37,554 |
| Depreciation Amortization | -1,421 | 248 | 212 | 264 | 531 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -479 |
| Accounts payable and accrued liabilities | -1,158 | 1,204 | -886 | 638 | -427 |
| Other Working Capital | 5,913 | 861 | -3,444 | 7,439 | -8,830 |
| Other Operating Activity | 9,308 | 4,903 | 9,506 | 6,879 | 9,265 |
| Operating Cash Flow | $-43,209 | $-30,326 | $-56,637 | $-42,556 | $-37,494 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -44,916 | 30,000 | -29,938 | N/A | -5,776 |
| PPE Investments | N/A | N/A | -16 | -8 | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 34,800 |
| Investing Cash Flow | $-44,916 | $30,000 | $-29,955 | $-8 | $29,024 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 388 | 305 | 1,220 | 194,496 | 41,902 |
| Other Financing Activity | -560 | -1,575 | 0 | 0 | 0 |
| Financing Cash Flow | $-171 | $-1,270 | $1,220 | $194,496 | $41,902 |
| Beginning Cash Position | 142,823 | 144,419 | 229,791 | 77,858 | 44,426 |
| End Cash Position | 54,527 | 142,823 | 144,419 | 229,791 | 77,858 |
| Net Cash Flow | $-88,296 | $-1,596 | $-85,372 | $151,933 | $33,433 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,209 | -30,326 | -56,637 | -42,556 | -37,494 |
| Capital Expenditure | N/A | N/A | -16 | -8 | N/A |
| Free Cash Flow | -43,209 | -30,326 | -56,654 | -42,564 | -37,494 |